System | Type | Disorder | Pubmed |
neuromuscular | myopathy | | |
myostatin inhibitors have entered clinical trials in patients with muscle wasting and degenerative diseases; inhibitors have the potential of increasing muscle regeneration through the effects of myostatin on myoblasts and also of inhibiting fibrosis th |
cardiovascular | aquired | | |
targeted inhibition of myostatin in cardiac cachexia might be a therapeutic option in the future |
obesity | | | |
. increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes |
diabete | | | |
. increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes |
diabete | | | |
altering the final stages of adipogenesis through targeted GDF8 exposure, may have therapeutic benefit in metabolic disaeses such as diabetes |
cancer | | | |
MSTN inhibition is a potential therapy for muscle wasting diseases, some of which are associated with a depletion of satellite cells |